HB 1169 requires Tennessee's Council on Children's Mental Health to submit annual reports starting June 30, 2026, detailing the statewide mental health system for children. The reports must cover current services (including state/federal programs), gaps in care, and recommendations for better coordination between agencies. The council must gather input from relevant departments (mental health, education, health, etc.) to create a comprehensive overview. These reports will be shared with the governor, legislative leaders, and agency heads. The bill, effective March 28, 2025, updates existing law to ensure regular oversight of children's mental health services.
HB 395, the "Tennessee Genomic Security and End Organ Harvesting Act," prohibits Tennessee health insurers from covering organ transplants or post-transplant care if the organ was sourced from China or procured through sale/donation originating in China. It also bans medical and research facilities from using genetic sequencing equipment or software produced by entities linked to "foreign adversaries" (specifically targeting China per the bill's context), requiring replacement within 180 days. Additionally, the bill mandates that all genetic sequencing data must be stored within the United States, with remote access from outside the country prohibited without approval from the state health commissioner. The law takes effect on January 1, 2026, directly affecting health insurers, hospitals, and research facilities operating in Tennessee.
HB 498 creates an advisory task force to review and recommend annual adjustments to state reimbursement rates paid to healthcare agencies in Tennessee. The task force, composed of 6 appointed members (3 by each legislative chamber, representing different health professions) and ex-officio agency representatives, will focus on ensuring rates cover agency costs, staff salaries, and administrative needs. It must submit annual recommendations by August 1, starting in 2026, to state officials and legislative committees, considering factors like provider costs, staff compensation, and workforce shortages. The bill directly affects healthcare agencies providing state-funded services, aiming to make reimbursement rates more adequate without changing existing funding levels.
HB 502 expands TennCare coverage to include diagnosis (including genetic testing) and treatment for Kleefstra syndrome, a rare genetic disorder affecting development and multiple body systems. It requires TennCare to provide this coverage in the same manner and extent as for autism spectrum disorder, Down syndrome (Trisomy 21), and other similar genetic disorders, when medically necessary. This applies to all enrolled individuals with Kleefstra syndrome and covers therapies, medications, assistive devices, and interventions aimed at improving quality of life. The law takes effect July 1, 2025, after being signed by the Governor in April 2025.
HJR 80 designates May 2025 as "National Hypertension Month" in Tennessee. The resolution urges healthcare providers, insurers, and TennCare to promote hypertension awareness and support coverage for renal denervation therapies, which treat resistant hypertension. It advocates for policy changes to improve access to innovative treatments but does not create new legal requirements. As a symbolic resolution, it encourages state-level action without mandating specific outcomes.
SB 282, the "Individualized Investigational Treatment Act," creates a legal framework for patients with life-threatening or severely debilitating illnesses to access personalized medical treatments (like gene therapies or vaccines tailored to their genetic profile) when standard FDA-approved options have been exhausted. It directly affects eligible patients (who must meet specific criteria including physician attestation and written informed consent) and eligible facilities (those complying with federal human subjects protections). Key provisions require detailed written consent covering all treatment options, risks, and financial liability, while clarifying that insurers, health plans, and providers are **not obligated** to cover these treatments or related costs (TCA §§ 63-6-1304(a)-(d)). The law takes effect July 1, 2025, and explicitly states that heirs cannot be held liable for unpaid treatment debts if a patient dies during treatment (TCA § 63-6-1305).
This bill adds hepatitis C antibody (anti-HCV) testing to the standard blood screening required for all pregnant women in Tennessee during initial prenatal visits and between weeks 28-32 of pregnancy. If the anti-HCV test is reactive, labs must automatically conduct a follow-up HCV RNA test without requiring additional orders. It directly affects all pregnant women receiving routine prenatal care in Tennessee, expanding the required screening panel to include hepatitis C alongside existing tests for syphilis, rubella, and hepatitis B. The changes take effect July 1, 2025, and align hepatitis C testing protocols with existing disease reporting requirements for maternal health.
HB 404 extends the professional music therapy advisory committee under Tennessee's psychology board until June 30, 2027. This bill updates Tennessee Code Sections 4-29-246 and 4-29-248 to formally maintain the committee's existence, preventing its automatic termination. The committee, which advises the Board of Examiners in Psychology on music therapy licensure, is directly affected by this extension. The change ensures continuity for this advisory body without altering any substantive licensing rules.
HB 1236, the "Tennessee Health SNAP Act," would require Tennessee's Department of Human Resources to seek a federal waiver from the USDA to prohibit SNAP (food stamp) benefits from being used to purchase candy and soft drinks. If approved, this restriction would directly affect SNAP recipients in Tennessee who currently use benefits for these items. The bill mandates that the waiver request include public health justification, a plan for retailer system updates, recipient education on healthy alternatives, and a tracking system for spending and health data. It also requires annual reports to state leaders on the waiver status and impact. The bill is pending Senate action and would take effect July 1, 2025, if enacted.
SB 610 requires TennCare to cover continuous glucose monitors (CGMs) for eligible members with specific diabetes conditions. It directly affects TennCare enrollees diagnosed with Type 1 diabetes, gestational diabetes, or Type 2 diabetes meeting documented criteria like frequent low blood sugar episodes, high A1C levels, or hospitalizations related to diabetes complications. The bill mandates coverage only when prescribed by an endocrinologist or diabetes specialist confirming the member meets the eligibility requirements. The law takes effect January 1, 2026.
